-- 根據《日經新聞》週一報道，Cyfuse Biomedical K.K（東京證券交易所代碼：4892）正推進其再生醫學平台進入人體試驗階段，一項旨在利用3D列印細胞構建體修復膝關節骨骼和軟骨的新療法即將問世。 這項由醫師主導、與慶應義塾大學和藤田保健衛生大學合作進行的研究，將測試由患者自身脂肪細胞製成的植入物。通報稱，該試驗預計最快於7月啟動，將招募5名患有特發性膝關節骨壞死的患者。 Cyfuse的技術利用活細胞製造無支架的三維組織，旨在實現更自然的整合並降低排斥風險。報導稱，這項膝關節計畫標誌著在解決骨骼和軟骨均受損的疾病方面邁出了重要一步，而目前除關節置換術外，此類疾病的治療選擇十分有限。 該公司已在臨床前研究中驗證了該療法的安全性，並將其定位為更廣泛的再生醫學產品線的一部分。據報道，今年早些時候，Cyfuse啟動了一項獨立的臨床研究，專注於使用類似的細胞結構進行神經修復。 （市場動態新聞來自與全球市場專業人士的對話。這些資訊據信來自可靠來源，但可能包含傳聞和推測。準確性無法保證。）
Related Articles
Asia
Hunan Gold Q1 Profit Up 79%, Revenue Climbs 44%
Hunan Gold (SHE:002155) posted first-quarter attributable net profit of 595.5 million yuan, up 79% from 332.3 million yuan the previous year.Earnings per share went up to 0.38 yuan from 0.21 yuan, according to a weekend filing with the Shenzhen bourse.Operating revenue climbed 44% year over year to 18.8 billion yuan from 13.1 billion yuan.Shares of the miner declined 2% in recent trade.
$SHE:002155
International
Singapore Manufacturing Output Rises 10% in March
Singapore's manufacturing output jumped 10.1% in March, backed by strong growth across almost all clusters, the city-state's Department of Statistics reported Monday.Excluding biomedical manufacturing, output rose 13.5% year-on-year in March.Electronics output grew 30%, driven by robust AI-related demand, the data showed. Precision engineering gained 14.0%, while general manufacturing and transport engineering expanded 7.6% and 2.0%, respectively.Meanwhile, biomedical manufacturing fell 14.3%, mainly due to softer demand for medical devices, while chemicals dropped 16.0%.On a month-on-month basis, manufacturing output increased 4.7% in March. Excluding biomedical manufacturing, output was up 3.5% on a monthly basis.
$^STI
Asia
G8 Education Says Macquarie Group Becomes Substantial Holder
G8 Education (ASX:GEM) said Macquarie Group (ASX:MQG) became a substantial holder on April 22 after acquiring 39.2 million securities of the firm, according to a Monday Australian bourse filing.Macquarie's voting power in the firm is now 5.08%.Its shares were up over 1% in recent trading on Monday.
$ASX:GEM$ASX:MQG